Prescription Drug Coverage

Trelegy Ellipta Medicare Coverage

You may be able to find Medicare plan options in your area that cover Trelegy Ellipta. Learn more about Trelegy Ellipta and find Medicare Advantage plans in your area that cover prescription drugs.
Trelegy Ellipta
Chemical name: Fluticasone/Umeclidinium/Vilanterol

Typical dosage: 100mcg/62.5mcg/25mcg

Typical type: Inhaler1

Trelegy Ellipta is a medication typically used to treat COPD. It is a brand name medication and is available as an inhaler with a dry powder for inhalation.

Trelegy Ellipta is a prescription medication that contains the active ingredients Fluticasone, Umeclidinium and Vilanterol.

Trelegy Ellipta is inhaled once daily for the maintenance treatment of airflow obstruction in patients with chronic obstructive pulmonary disease (COPD) – including bronchitis and/or emphysema – and to reduce COPD exacerbations in patients with a history of exacerbations.

Trelegy Ellipta works to reduce inflammation and to cause the throat muscles to relax.

The major side effects of Trelegy Ellipta include headache, diarrhea or constipation, back and joint pain, flu like symptoms and respiratory problems.

How much does Trelegy Ellipta cost with Medicare?

Trelegy Ellipta coverage and costs may vary based on the specific plan you have, as well as what coverage stage you're in.

Contact your plan carrier or consult your plan formulary for more cost information.

Does Medicare cover Trelegy Ellipta?

According to GoodRx, 96% of Medicare Advantage plans and Medicare Part D plans covered Trelegy Ellipta in 2023.1

  • Medicare Advantage plans or Part D plans that cover Trelegy Ellipta include copay amounts that can range widely from one plan to another. Plan members may also be responsible for meeting a deductible before the plan’s drug coverage kicks in.

  • Medicare Advantage plans that offer prescription drug coverage are called Medicare Advantage Prescription Drug Plans (MA-PD). 89% of 2024 Medicare Advantage plans include prescription drug coverage.2

  • Medicare prescription drugs plans each have their own formulary, or drug list, that details what prescription drugs are covered by the plan and how they are covered.

Drug coverage may vary based on plan availability. You may be able to find Medicare Advantage plan options in your area that cover Trelegy Ellipta. We represent carriers such as Humana, UnitedHealthcare®, Anthem Blue Cross and Blue Shield, Aetna, Cigna Healthcare, Wellcare, or Kaiser Permanente.

You can also compare Part D prescription drug plans available where you live and enroll in a Medicare prescription drug plan online when you visit MyRxPlans.com.

Additional information

Trelegy Ellipta can cause a mouth infection called thrush. To avoid getting thrush, rinse your mouth out with water after each use. Do not swallow the water.

Try to take Trelegy Ellipta at the same time of day every day and do not miss doses.

Call your doctor right away if your breathing problems get worse or if you have any signs of pneumonia.

Trelegy Ellipta can increase the risk of infection. Wash your hands often and avoid sick people as much as possible.

Long term use can increase the risk of cataracts or glaucoma. Talk to your doctor and have eye exams as instructed.

Compare plans today.

Speak with a licensed insurance agent

1-800-557-6059

 

This article is for informational purposes only. It is not healthcare advice, treatment, or diagnosis. It is not an endorsement of or recommendation for this medication. Speak to your doctor or healthcare provider about your specific healthcare needs, including your prescription medications. Only take medication as directed by your doctor.

Coverage and costs of prescription medications will vary by Medicare plan. Not all plans are available in all areas.

Written by Hayden Gharibyar, Pharm.D.

1 GoodRx. Trelegy Ellipta. Retrieved November 2023, from www.goodrx.com/Trelegy-Ellipta/medicare-coverage.

2 Freed M, et al. (Nov 15, 2023). Medicare Advantage 2024 Spotlight: First Look. Kaiser Family Foundation. www.kff.org/medicare/issue-brief/medicare-advantage-2024-spotlight-first-look.